Characterization of invasive Group B < em > Streptococcus < /em > isolates from Western Australian infants, 2004-2020
Conclusions. Based on comprehensive characterization of invasive infant GBS in Western Australia, we found that coverage for leading capsular polysaccharide and surface protein vaccine candidates was high. The demonstrated changes in serotype and molecular type highlight the need for ongoing surveillance, particularly with regard to future GBS vaccination programmes. The reduced susceptibility to IAP agents over time should inform changes to antibiotic guidelines.PMID:38567639 | DOI:10.1099/jmm.0.001822
Source: Journal of Medical Microbiology - Category: Microbiology Authors: Ginger Hilpipre Lucy L Furfaro Michelle Porter Christopher C Blyth Daniel K Yeoh Source Type: research
More News: Australia Health | Clindamycin | Clinical Trials | Ginger | Microbiology | Penicillin | Vaccines